Skip to main content
. 2019 Jun 3;18(13):1513–1522. doi: 10.1080/15384101.2019.1624113

Figure 1.

Figure 1.

HER2 mutations cause oncogenic transformation of MCF10A. (a) Structure visualizations of the HER2 somatic mutations, TM, transmembrane region. (b) Western blotting showing the expression of HER2 in indicated MCF10A cells. β-actin was used as a loading control. (c) Proliferation data for indicated MCF10A cells grown in monolayer for 4 days. (D) Soft agar assay of indicated MCF10A cells for 14 days. Data are expressed as means ± SEM of three technical replicates.